enow.com Web Search

  1. Ads

    related to: difference between xiidra and restasis

Search results

  1. Results from the WOW.Com Content Network
  2. Lifitegrast - Wikipedia

    en.wikipedia.org/wiki/Lifitegrast

    Lifitegrast, sold under the brand name Xiidra (/ ˈ z aɪ d r ə / [2]), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. [ 3 ]

  3. Dry eye syndrome - Wikipedia

    en.wikipedia.org/wiki/Dry_eye_syndrome

    There are two potential connections between contact usage and dry eye. Traditionally, it was believed that soft contact lenses, which float on the tear film that covers the cornea, absorb the tears in the eyes. [4] The connection between a loss in nerve sensitivity and tear production is also the subject of current research. [27]

  4. Ciclosporin - Wikipedia

    en.wikipedia.org/wiki/Ciclosporin

    Ciclosporin is indicated to treat and prevent graft-versus-host disease in bone marrow transplantation and to prevent rejection of kidney, heart, and liver transplants. [8] [7] It is also approved in the US for treating of rheumatoid arthritis and psoriasis, persistent nummular keratitis following adenoviral keratoconjunctivitis, [25] [7] and as eye drops for treating dry eyes caused by ...

  5. Oyster Point's drug becomes first FDA-approved nasal spray to ...

    www.aol.com/finance/fda-approves-oyster-points...

    Prescription eye drops, such as Novartis' Xiidra, AbbVie Inc's Restasis and Sun Pharmaceutical's Cequa are also used to treat dry eye disease. Oyster Point said Tyrvaya, a twice daily nasal spray ...

  6. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  7. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    The Supreme Court decided that the substance that Novartis sought to patent was indeed a modification of a known drug (the raw form of imatinib, which was publicly disclosed in the 1993 patent application and in scientific articles), that Novartis did not present evidence of a difference in therapeutic efficacy between the final form of Gleevec ...

  1. Ads

    related to: difference between xiidra and restasis